Literature DB >> 3498757

Interleukin 1 production by human lung tissue. I. Identification and characterization.

B S Bochner1, S D Landy, M Plaut, C A Dinarello, R P Schleimer.   

Abstract

Crucial to the development of inflammatory infiltrates is the localized production of mediators which promote adherence of leukocytes to the vascular endothelium. Previous in vitro studies, using monolayers of cultured human vascular endothelial cells (VEC), have identified various agents which promote the acquisition of adhesiveness in VEC for polymorphonuclear leukocytes. In the present studies, we report that human lung fragments cultured for 4 to 24 hr release a factor which acts on VEC to promote adherence of polymorphonuclear leukocytes. Adhesiveness in VEC stimulated by lung fragment culture supernatants was time- and dose-dependent. This adherence-promoting factor appears to be a mixture of the alpha and beta forms of interleukin 1 (IL-1) and has the following properties: 1) it is heat-labile; 2) it is not inactivated by polymyxin B; 3) it has mobility on Sephadex G-75 column chromatography corresponding to apparent m.w. of approximately 15,000, 30,000, and 70,000 (a pattern observed previously for IL-1); 4) it has activity in the thymocyte costimulation IL-1 assay, but no interleukin 2 activity, and 5) it is neutralized by anti-human IL-1 antisera but not by anti-human tumor necrosis factor antiserum. Production and release of IL-1 in vivo may play a role in the development of inflammatory infiltrates in human lung and other tissues by acting on endothelium to promote the localized adherence of leukocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498757

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  "Siglec"ting the allergic response for therapeutic targeting.

Authors:  Bruce S Bochner
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

2.  Phenotypic characterization of alveolar capillary endothelial cells, alveolar epithelial cells and alveolar macrophages in patients with pulmonary fibrosis, with special reference to MHC class II antigens.

Authors:  T Komatsu; M Yamamoto; K Shimokata; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.

Authors:  A Schuster; A Haarmann; V Wahn
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue.

Authors:  M Kato; R P Schleimer
Journal:  Lung       Date:  1994       Impact factor: 2.584

Review 5.  Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.

Authors:  Leo F Buckley; George F Wohlford; Clara Ting; Abdullah Alahmed; Benjamin W Van Tassell; Antonio Abbate; John W Devlin; Peter Libby
Journal:  Crit Care Explor       Date:  2020-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.